Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM

Medical Xpress

Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM

이 뉴스, 어떠셨어요?

한 번의 탭으로 반응을 남겨요 · 로그인 불필요

For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with more meaningful reductions in hemoglobin A1C (HbA1c) levels than semaglutide, according to a study published online June 30 in the Annals of Internal Medicine. ...

전문 보기

Bofanglutide linked to meaningful reductions in HbA1c in adults with T2DM

이 뉴스, 어떠셨어요?

관련 뉴스

'science' 카테고리 뉴스

Zero-waste plastic and color recycling: The end of colored plastic downgrading could be near

Dual-mobility hip replacement implant can lower dislocation risk by 70%

Single ion maps 3D electromagnetic fields above chips with record sensitivity

Medical Xpress의 다른 기사

FDA approves Tzield for children with new stage 3 type 1 diabetes

New drug unlocks elusive immune receptor, opening path toward motor neuron disease treatments

EHA: Adding Pirtobrutinib to Venetoclax-Rituximab ups progression-free survival in chronic lymphocytic leukemia